Fig. 3.
Measles-associated hospitalizations and measles virus genotypes isolated in Victoria (1962–2004) during WHO-defined measles elimination phases20,40,41,a
MCC, measles control campaign; MMR, measles–mumps–rubella vaccine; m.o., months’ old; y.o., years’ old.
a Arrows reflect changes to measles immunization policy. Boxes show genotypes detected retrospectively (pre–1999) from measles virus isolates and clinical samples during the measles control phase. Measles virus isolates prospectively (1999–2004) detected during the elimination phase represent genotypes associated with imported cases or vaccine-related illness (not shown in figure). Prospectively isolated genotypes (number of isolates) include A (4 isolates detected), D3 (1), D4 (2), D5 (4), D7 (1), D8 (4), D9 (2), G2 (2), G3 (2), H1 (2) and H2 (1).
